Latest Developments in U.S. Cannabis Policy and Research
Federal Legislative Efforts to Protect Hemp Products
Three Republican members of Congress have introduced separate amendments to a large‑scale agriculture bill aimed at blocking a scheduled federal ban on hemp‑derived THC products set to take effect in November. Representative Andy Barr (R‑KY) proposes keeping many currently legal hemp items on the market, adding labeling requirements, and instituting new sales taxes, among other regulatory reforms. The amendments reflect growing concern among lawmakers that the impending ban could disrupt a rapidly expanding hemp sector.
State‑Level Enforcement and Penalties
Louisiana Governor Jeff Landry (R) signed legislation that could send individuals to jail for up to one year if they smoke marijuana within 2,000 feet of any school property, including college campuses. The measure tightens existing distance‑based restrictions and underscores a trend toward stricter enforcement in certain states despite broader moves toward reform.
Medical Cannabis and Gun Rights
A report from the Hawaii Attorney General’s office reveals that more residents are being denied gun permits because of their status as medical cannabis patients than for any other reason. The data highlight the ongoing tension between state‑legal medical marijuana programs and federal firearms regulations, which still classify cannabis users as prohibited possessors.
Research Highlights: Cannabinoids in Cancer Therapy
A recent scientific review concluded that cannabinoids demonstrated consistent and statistically significant antitumor effects in glioblastoma and breast cancer models, with supportive evidence also appearing in lung and prostate cancer studies. The authors note that cannabinoids show promise as adjuncts in oncotherapy, potentially enhancing the efficacy of standard chemotherapy regimens.
State Regulators Seek Federal Rescheduling Clarity
Top marijuana regulators from several states voiced frustration over the lack of clear guidance from federal agencies following the Trump administration’s move to reschedule cannabis from Schedule I to Schedule III. Officials said they cannot effectively advise licensees amid the uncertainty, describing the situation as “incredibly frustrating, especially with a ticking clock.”
Additional State and Local News
In South Carolina, Republican attorney‑general candidates debated their positions on medical cannabis legalization during a primary forum. Tennessee announced that new rules banning the sale of THCA and other hemp‑derived products will take effect on July 1. Meanwhile, Missouri retailers reported $129.6 million in legal marijuana sales for April, illustrating the continued growth of the state’s adult‑use market.
On the business front, Robinhood added several cannabis‑related companies to its platform in read‑only mode, while Charlotte’s Web Holdings secured an additional $10 million equity investment from a British American Tobacco subsidiary. SHF Holdings (Safe Harbor Financial) appointed two new board members, signaling ongoing interest from traditional financial sectors.
International and Scientific Updates
Guatemalan President Bernardo Aréval denied claims that his administration has reached an agreement with the United States to conduct anti‑drug trafficking operations within the country. In the health sphere, a study on fibromyalgia found that 40 % of participants treated with cannabis experienced clinically meaningful improvement, compared with only 10 % of those receiving a placebo.
Advocacy, Business, and Market Movements
The American Trade Association for Cannabis and Hemp launched a round‑up initiative that lets dispensary customers add the difference to the nearest dollar on their purchases, with the pooled funds earmarked for federal marijuana rescheduling efforts. Such grassroots funding models aim to bolster advocacy campaigns while engaging consumers directly.
For more details on the GOP lawmakers’ effort to protect hemp, see Here.
